This dynamic new software powers Sepragen’s line of pilot and process scale chromatography systems. These systems are being used by Sepragen’s biotech customers to “scale-up” their processes in order to produce purified material for later stage clinical trials and biotech drug manufacturing. Sepragen’s biotech customers include, Smith-Kline Beechman, Schering Plough, Baxter International, Glaxo Wellcome, Chiron, Merck and Roche Diagnostics.

Vinit Saxena, Sepragen’s Chairman and CEO stated, “Our technologies enable our biotech and gene therapy customers to produce large quantities of product quickly, for clinical testing, which accelerates their time to market. More established customers find that our technology and products enable cost-effective, predictable “scale-up” of their purification process for commercial launch.”

Sepragen Corporation develops and markets technology along with equipment and supplies for process chromatography applications. Sepragen has developed a number of patented applications that provide large market opportunities in the food and beverage industry, including debittering citrus juices, extracting isoflavone (plant estrogen) from soy, as well as extracting proteins from whey. The company holds over 14 issued patents relating to its core technology.